RECORD // Company

Anaptysbio, Inc

Formerly: ANAPTYSBIO INC; ANAPTYS BIOSCIENCES INC

Built 2026-11-21T11:39:22Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
  • ANAPTYSBIO, INC. · legal entity in this company's GLEIF ownership tree (LEI 529900HH4WQT03IG1A12)
SEC EDGAR (1)
Records under a former name (2)

The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.

Matched by name only, not merged (7)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • ANAPTYSBIO INC · Ca business · same registered legal name as 'ANAPTYSBIO, INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • AnaptysBio, Inc. · Ctgov · same registered legal name as 'ANAPTYSBIO, INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANAPTYSBIO INC · Epa echo · same registered legal name as 'ANAPTYSBIO, INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANAPTYSBIO INC · Epa echo · same registered legal name as 'ANAPTYSBIO, INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANAPTYSBIO INC · Epa echo · same registered legal name as 'ANAPTYSBIO, INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANAPTYSBIO INC · Epa rcra · same registered legal name as 'ANAPTYSBIO, INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ANAPTYSBIO, INC. · USAspending · same registered legal name as 'ANAPTYSBIO, INC' Possible match based on name, not a shared identifier. Compare the records. Compare

3 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001193125-26-458494

ItemValuePeriodFormFiledAccessionReport
Revenue$30,274,0003 months ended 2026-09-3010-Q2026-11-120001193125-26-4584942026-11-21 11:39 UTCReport an error
Net income (loss)$3,876,0003 months ended 2026-09-3010-Q2026-11-120001193125-26-4584942026-11-21 11:39 UTCReport an error
Cash and cash equivalents$135,394,000at 2026-09-3010-Q2026-11-120001193125-26-4584942026-11-21 11:39 UTCReport an error

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001370053
Ticker
ANAB
EIN
203828755
CUSIP
032724106
Record ID
sx:sec:0001370053

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

33 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-18SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-18SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
State of incorporationDE2026-11-18SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
Fiscal year end (MMDD)06302026-11-18SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
Business address10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 921212026-11-18SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
ExchangesNasdaq2026-11-18SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$234,603,0002025-12-3110-KT, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-21 11:39 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-13,232,0002025-12-3110-KT, XBRL NetIncomeLoss2026-11-21 11:39 UTCReport an error
Total assets (at 2026-06-30)$316,984,0002026-06-3010-KT, XBRL Assets2026-11-21 11:39 UTCReport an error
Stockholders' equity (at 2026-06-30)$10,585,0002026-06-3010-KT, XBRL StockholdersEquity2026-11-21 11:39 UTCReport an error
Cash and cash equivalents (at 2026-06-30)$133,826,0002026-06-3010-KT, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-21 11:39 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$19,697,0002025-12-3110-KT, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 11:39 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$87,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 11:39 UTCReport an error
Operating lease liabilities (at 2026-06-30)$13,095,0002026-06-3010-KT, XBRL OperatingLeaseLiability2026-11-21 11:39 UTCReport an error
Form D total offering amount (D filed 2015-07-24)$40,767,2772015-07-24D2026-11-21 11:39 UTCReport an error
Form D total amount sold (D filed 2015-07-24)$40,767,2772015-07-24D2026-11-21 11:39 UTCReport an error
Form D industry groupBiotechnology2015-07-24D2026-11-21 11:39 UTCReport an error
Form D revenue rangeDecline to Disclose2015-07-24D2026-11-21 11:39 UTCReport an error
Form D date of first sale2015-07-132015-07-24D2026-11-21 11:39 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-12)On November 12, 2026, AnaptysBio, Inc. (“AnaptysBio”) issued a press release announcing its financial results for the three months ended September 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02, including Exhibit 99.1 to this Current Report on Form 8-K, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be incorporated by…2026-11-12SEC EDGAR 8-K 0001193125-26-458461 (text as filed, excerpt)2026-11-21 11:39 UTCReport an error
8-K Item 5.07, Submission of Matters to a Vote of Security Holders (filed 2026-08-11)On August 11, 2026, AnaptysBio, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders and the following proposals were adopted: 1. Election of two Class III directors, Hollings Renton and John P. Schmid, each to serve a three-year term, which will expire at the 2029 Annual Meeting of Stockholders or until such time as his respective successor has been duly elected and qualified or until such director’s earlier resignation or removal: Nominees Shares For Shares Withheld / Abstaining Broker Non-Votes Hollings Renton 15,304,522 6,613,642 2,084,465 John P. Schmid 20,314,669 1,603,495 2,084,465 2. Ratification of the appointment of KPMG LLP as the Company’s independent registered…2026-08-11SEC EDGAR 8-K 0001193125-26-344583 (text as filed, excerpt)2026-11-21 11:39 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-07-30)As previously disclosed, on November 20, 2025, AnaptysBio, Inc. (the “Company”) filed a Verified Complaint in Delaware Court of Chancery (the “Court”), requesting a court declaration that TESARO, Inc. (“Tesaro”) has materially breached the parties’ Collaboration and Exclusive License Agreement (“Collaboration Agreement”) and that GlaxoSmithKline (together with Tesaro and TESARO Development, Ltd., the “Defendants”), Tesaro’s corporate parent, has tortiously interfered with the Collaboration Agreement. The litigation was subsequently consolidated with a case filed against the Company by Tesaro and TESARO Development, Ltd., and captioned In re Tesaro, Inc. Litigation, C.A. No. 2025-1357-KSJM.…2026-07-30SEC EDGAR 8-K 0001193125-26-326097 (text as filed, excerpt)2026-11-21 11:39 UTCReport an error
Plan (pension, plan no. 001)ANAPTYSBIO, INC. 401(K) PLAN: 187 participants, assets $30,969,9072025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:39 UTCReport an error
Largest institutional holder #1 (13F as filed): EcoR1 Capital, LLC$531,906,3452026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #2 (13F as filed): BlackRock, Inc.$124,473,3102026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #3 (13F as filed): TANG CAPITAL MANAGEMENT LLC$89,834,3332026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #4 (13F as filed): STATE STREET CORP$86,818,0952026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #5 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$61,170,7282026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #6 (13F as filed): Affinity Asset Advisors, LLC$55,762,3582026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #7 (13F as filed): Sanofi$55,479,3982026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #8 (13F as filed): MILLENNIUM MANAGEMENT LLC$54,493,8302026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #9 (13F as filed): Woodline Partners LP$48,398,4452026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #10 (13F as filed): 683 Capital Management, LLC$44,550,0012026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.